Cisplatin has been shown to activate PI3K/Akt in several cancer cell lines (51), suggesting that even in NB chemotherapy induced Akt might drive phosphorylation of p21, thereby shifting the balance towards its oncogenic properties (16). Here, CDKN1A is linked to cancer.